ÂÜÀòÂÒÂ×

The Board Members at Mellitus provide strategic oversight, governance, and guidance to ensure the successful development and commercialization of the company's novel diagnostic tests. They bring diverse expertise to shape the company’s vision, support executive decisions, and oversee financial and operational health, with a particular emphasis on the lead product candidate for Gestational Diabetes Mellitus (GDM).